Sputum eosinophilia and bronchial responsiveness in patients with chronic non-productive cough responsive to anti-asthma therapy

Respirology

Volumn 8, Issue 2, 2003, Pages 168-174

  Fujimoto, Keisaku ^a   Yamaguchi, Shinji ^a   Urushibata, Kazuhisa ^a   Koizumi, Tomonobu ^a   kubo, Keishi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bronchial asthma; Bronchial responsiveness; Chronic cough; Eosinophil; Sputum

Indexed keywords

ANTIALLERGIC AGENT; ANTIASTHMATIC AGENT; AZELASTINE; BECLOMETASONE DIPROPIONATE; BRONCHODILATING AGENT; EOSINOPHIL CATIONIC PROTEIN; GLUCOCORTICOID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; METHACHOLINE; PRANLUKAST; PREDNISOLONE; SERATRODAST; THROMBOXANE RECEPTOR BLOCKING AGENT;

ADULT; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; COUGHING; EOSINOPHIL; EOSINOPHILIA; FEMALE; HUMAN; HUMAN CELL; INFLAMMATORY CELL; MALE; NEUTROPHIL; PRIORITY JOURNAL; REMISSION; SPUTUM; SPUTUM ANALYSIS; TREATMENT OUTCOME;

ADULT; AGED; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; BRONCHODILATOR AGENTS; CHROMONES; CHRONIC DISEASE; COUGH; EOSINOPHILIA; FEMALE; HUMANS; LEUKOTRIENE ANTAGONISTS; MALE; MIDDLE AGED; SPUTUM; TREATMENT OUTCOME;

EID: 0038271816     PISSN: 13237799     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1843.2003.00448.x     Document Type: Article

References (27)

1. Wynder EL, Lemon FR, Mantel N. Epidemiology of persistent cough. Am. Rev. Respir. Dis. 1965; 91: 679-700.
2. Irwin RS, Curley FJ, French CL. Chronic cough. The spectrum and frequency of causes, key components of the diagnostic evaluation and outcome of specific therapy. Am. Rev. Respir. Dis. 1990; 141: 640-7.
3. Carney IK, Gibson PG, Murree-Allen K, Saltos N, Olson LG, Hensley MJ. A systematic evaluation of mechanisms in chronic cough. Am. J. Respir. Crit. Care Med. 1997; 156: 211-6.
4. McGarvey LP, Heaney LG, Lawson JT et al. Evaluation and outcome of patients with chronic non-productive cough using a comprehensive diagnostic protocol. Thorax 1998; 53: 738-43.
5. Corrao WM, Braman SS, Irwin RS. Chronic cough as the sole presenting manifestation of bronchial asthma. N. Engl. J. Med. 1979; 300: 633-7.
6. Doan T, Patterson R, Greenberger PA. Cough variant asthma: usefulness of a diagnostic-therapeutic trial with prednisone. Ann. Allergy 1992; 69: 505-9.
7. Cheriyan S, Greenberger PA, Patterson R. Outcome of cough variant asthma treated with inhaled steroids. Ann. Allergy 1994; 73: 478-80.
8. Niimi A, Amitani R, Suzuki K, Tanaka E, Murayama T, Kuze F. Eosinophilic inflammation in cough variant asthma. Eur. Respir. J. 1998; 11: 1064-9.
9. Gibson PG, Dolovich J, Denburg J, Ramsdale EH, Hargreave FE. Chronic cough: eosinophilic bronchitis without asthma. Lancet 1989; 1: 1346-8.
10. Gibson PG, Hargreave FE, Girgis-Gabardo A, Morris M, Denburg JA, Dolovich J. Chronic cough with eosinophilic bronchitis: examination for variable airflow obstruction and response to corticosteroid. Clin. Exp. Allergy 1995; 25: 127-32.
11. Fujimura M, Ogawa H, Yasui M, Matsuda T. Eosinophilic tracheobronchitis and airway cough hypersensitivity in chronic non-productive cough. Clin. Exp. Allergy 2000; 30: 41-7.
12. Takishima T, Hida W, Sasaki H, Suzuki S, Sasaki T. Direct-writing recorder of the dose-response curves of the airway to methacholine. Chest 1981; 80: 600-6.
13. Mochizuki H, Shigeta M, Kato M, Maeda S, Shimizu T, Mirokawa A. Age-related changes in bronchial hyperreactivity to methacholine in asthmatic children. Am. J. Respir. Crit. Care Med. 1995; 152: 906-10.
14. Fujimoto K, Kubo K, Matsuzawa Y, Sekiguchi M. Eosinophil cationic protein levels in induced sputum correlate with the severity of bronchial asthma. Chest 1997; 112: 1241-7.
15. Pizzichini MM, Pizzichini E, Parameswaran K et al. Nonasthmatic chronic cough: No effect of treatment with an inhaled corticosteroid in patients without sputum eosinophilia. Can. Respir. J. 1999; 6: 323-30.
16. Niimi A, Matsumoto H, Minakuchi M, Kitaichi M, Amitani R. Airway remodelling in cough-variant asthma. Lancet 2000; 356: 564-5.
17. Kaminsky DA, Irvin CG, Gurka DA et al. Peripheral airways responsiveness to cool, dry air in normal and asthmatic individuals. Am. J. Respir. Crit. Care Med. 1995; 152: 1784-90.
18. Brightling CE, Ward R, Wardlaw AJ, Pavord ID. Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis. Eur. Respir. J. 2000; 15: 682-6.
19. Kamikawa Y. Inhibitory effect of anti-allergic drugs on cholinergic and non-cholinergic neurotransmissions of guinea pig bronchial muscle in vitro. Ann. Allergy 1989; 63: 59-63.
20. Nieber K, Baumgarten C, Rathsack R et al. Effect of azelastine on substance P content in bronchoalveolar and nasal lavage fluids of patients with allergic asthma. Clin. Exp. Allergy 1993; 23: 69-71.
21. Fujimura M, Kamio Y, Hashimoto T, Matsuda T. Cough receptor sensitivity and bronchial responsiveness in patients with only chronic nonproductive cough: In view of effect of bronchodilator therapy. J. Asthma 1994; 31: 463-72.
22. Fujimura M, Sakamoto S, Kamio Y, Bando T, Kurashima K, Matsuda T. Effect of inhaled procaterol on cough receptor sensitivity to capsaicin in patients with asthma or chronic bronchitis and in normal subjects. Thorax 1993; 48: 615-18.
23. Fuller RW, Collier JG. Sodium cromoglycate and atropine block the fall in FEV1 but not the cough induced by hypotonic mist. Thorax 1984; 39: 766-70.
24. Koh YY, Chae SA, Min KU. Cough variant asthma is associated with a higher wheezing threshold than classic asthma. Clin. Exp. Allergy 1993; 23: 696-701.
25. Widdicombe JG. Neurophysiology of the cough reflex. Eur. Respir. J. 1995; 8: 1193-202.
26. Advenier C, Lagente V, Boichot E. The role of tachykinin receptor antagonists in the prevention of bronchial hyperresponsiveness, airway inflammation and cough. Eur. Respir. J. 1997; 10: 1892-906.
27. Fujimura M, Ogawa H, Nishizawa Y, Nishi K. Comparison of atopic cough with cough variant asthma: is atopic cough a precursor of asthma? Thorax 2003; 58: 14-18.